Skip to main navigation Skip to search Skip to main content

NEMF mutations that impair ribosome-associated quality control are associated with neuromuscular disease

  • Paige B. Martin
  • , Yu Kigoshi-Tansho
  • , Roger B. Sher
  • , Gianina Ravenscroft
  • , Jennifer E. Stauffer
  • , Rajesh Kumar
  • , Ryo Yonashiro
  • , Tina Müller
  • , Christopher Griffith
  • , William Allen
  • , Davut Pehlivan
  • , Tamar Haral
  • , Martin Zenker
  • , Denise Howting
  • , Denny Schanze
  • , Eissa A. Faqeih
  • , Naif A.M. Almontashiri
  • , Reza Maroofian
  • , Henry Houlden
  • , Neda Mazaheri
  • Hamid Galehdari, Ganka Douglas, Jennifer E. Posey, Monique Ryan, James R. Lupski, Nigel G. Laing, Claudio A.P. Joazeiro, Gregory A. Cox
  • Jackson Laboratory
  • University of Maine
  • Heidelberg University 
  • Western Australia Institute for Medical Research
  • University of Florida
  • University of South Florida
  • Mission Health
  • Baylor College of Medicine
  • Hadassah University Medical Centre
  • Otto von Guericke University Magdeburg
  • King Fahad Medical City
  • Taibah University
  • University College London
  • University College London Hospitals NHS Foundation Trust
  • Shahid Chamran University of Ahvaz
  • OPKO Health, Inc.
  • Royal Children's Hospital Melbourne
  • Murdoch Children's Research Institute
  • Texas Children's Hospital Houston
  • Scripps Research

Research output: Contribution to journalArticlepeer-review

85 Scopus citations

Abstract

A hallmark of neurodegeneration is defective protein quality control. The E3 ligase Listerin (LTN1/Ltn1) acts in a specialized protein quality control pathway—Ribosome-associated Quality Control (RQC)—by mediating proteolytic targeting of incomplete polypeptides produced by ribosome stalling, and Ltn1 mutation leads to neurodegeneration in mice. Whether neurodegeneration results from defective RQC and whether defective RQC contributes to human disease have remained unknown. Here we show that three independently-generated mouse models with mutations in a different component of the RQC complex, NEMF/Rqc2, develop progressive motor neuron degeneration. Equivalent mutations in yeast Rqc2 selectively interfere with its ability to modify aberrant translation products with C-terminal tails which assist with RQC-mediated protein degradation, suggesting a pathomechanism. Finally, we identify NEMF mutations expected to interfere with function in patients from seven families presenting juvenile neuromuscular disease. These uncover NEMF’s role in translational homeostasis in the nervous system and implicate RQC dysfunction in causing neurodegeneration.

Original languageEnglish
Article number4625
JournalNature Communications
Volume11
Issue number1
DOIs
StatePublished - Dec 1 2020

Fingerprint

Dive into the research topics of 'NEMF mutations that impair ribosome-associated quality control are associated with neuromuscular disease'. Together they form a unique fingerprint.

Cite this